NCT01937221View on ClinicalTrials.gov

Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Mild Cognitive ImpairmentMild to Moderate Cognitive Impairment
Interventions
OTHER

spectral-domain optical coherence tomography (SD-OCT)

Intervention same to all groups.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Duke Institute for Brain Sciences

UNKNOWN

collaborator

Alzheimer's Association

OTHER

collaborator

Duke-NUS Graduate Medical School

OTHER

lead

Duke University

OTHER

NCT01937221 - Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease | Biotech Hunter | Biotech Hunter